Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Artivion, Inc.

Market Cap 1B 868M 800M 750M 1.4B 95.75B 1.43B 9.54B 3.69B 46.15B 3.75B 3.67B 160B P/E Ratio 2026 *
166x
P/E Ratio 2027 * 48.2x
Enterprise Value 1B 868M 800M 750M 1.4B 95.75B 1.43B 9.54B 3.69B 46.15B 3.75B 3.67B 160B EV / Sales 2026 *
2.06x
EV / Sales 2027 * 1.85x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week-0.35%
Current month-9.64%
1 month-13.20%
3 months-44.57%
6 months-55.56%
Current year-56.04%
1 week 19.82
Extreme 19.82
21.24
1 month 19.82
Extreme 19.82
24.7
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer 56 01/06/2023
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Date Insider Type Main position Quantity % Market Cap.
06-02Others

Director

-12,650 0.0261%
06-01Other

General Counsel

104,260 0.2148%
05-18Free

Director

7,576 0.0156%
Change 5-day change 1-year change 3-year change Capi.($)
-1.24%-0.35%-30.24%+27.06% 1B
-2.55%-4.12%-36.01%-13.89% 156B
-1.25%-2.61%-10.11%-5.62% 103B
+0.05%+2.38%-4.56%+57.03% 54.77B
+3.00%+0.30%+55.27%+51.53% 53.52B
-1.90%-3.79%-16.64%-41.99% 40.6B
-4.71%+4.85% - - 31.4B
-1.85%+1.48%-10.76%-41.74% 29.04B
-0.78%+4.85%+46.61%-7.74% 23.34B
-2.85%-3.53%-16.97%-1.50% 20.81B
Average -1.33%+1.42%-2.60%+2.57% 51.38B
Weighted average by Cap. -1.30%+0.39%-8.79%+0.06%

Financials

2026 *2027 *
Net sales 486M 422M 389M 365M 681M 46.57B 695M 4.64B 1.8B 22.45B 1.83B 1.79B 78.06B 540M 469M 432M 405M 756M 51.7B 772M 5.15B 1.99B 24.92B 2.03B 1.98B 86.66B
Net income 5.11M 4.43M 4.08M 3.83M 7.15M 489M 7.3M 48.72M 18.86M 236M 19.17M 18.75M 819M 22.61M 19.62M 18.09M 16.95M 31.67M 2.17B 32.33M 216M 83.54M 1.04B 84.88M 83.05M 3.63B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
12/06/26 20.12 $ -2.33% 38,694
11/06/26 20.60 $ +0.64% 794,512
10/06/26 20.47 $ -1.96% 799,698
09/06/26 20.88 $ +2.40% 1,120,728
08/06/26 20.39 $ +1.34% 816,993
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
20.60USD
Average target price
42.00USD
Spread / Average Target
+103.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!